Stay updated on KarMMa Clinical Trial: bb2121 in RRMM
Sign up to get notified when there's something new on the KarMMa Clinical Trial: bb2121 in RRMM page.

Latest updates to the KarMMa Clinical Trial: bb2121 in RRMM page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check14 days agoChange DetectedThe web page has been updated to reflect an increase in study locations from 24 to 48, and it now includes new locations in various countries, enhancing the geographical scope of the clinical trial. Additionally, the overall response rate and other key metrics related to the study have been revised and expanded.SummaryDifference72%
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check57 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and eligibility criteria for the bb2121 treatment for multiple myeloma, while retaining the study identifier and revision number.SummaryDifference25%
- Check64 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to KarMMa Clinical Trial: bb2121 in RRMM
Enter your email address, and we'll notify you when there's something new on the KarMMa Clinical Trial: bb2121 in RRMM page.